amplifAI Health, headquartered in Saudi Arabia, and Healthspan Digital, based in Toronto, have announced a strategic partnership to revolutionize precision health and longevity care in the Middle East and North Africa. The collaboration combines amplifAI Health’s AI-powered thermal hyperspectral technology with Healthspan Digital’s advanced longevity clinical protocols, aiming to provide rapid and cost-effective vascular age analysis.

Age-related diseases present a significant challenge globally — particularly in developed nations. Vascular aging, a key contributor to long-term disability and mortality among older adults, is closely linked to organ function decline and various age-related ailments. Therefore, understanding the mechanisms of this process and developing early detection techniques could significantly extend and improve the lives of millions worldwide.

Vascular aging lacks universal markers, making early detection challenging. However, a common form of vascular aging, peripheral arterial disease, can be detected through thermography by analyzing asymmetries and local temperature changes.

A notable limitation of thermography lies in the capacity of human operators to observe, analyze, and interpret thermograms accurately. AI algorithms address this limitation by objectifying findings, reducing variability, and improving accuracy and reliability. Computer-aided thermography also promises faster throughput and centralized processing, enhancing diagnostic outcomes.

Dr. Fady Hannah-Shmouni, CEO and Founder of Healthspan Digital, and a Dubai-based endocrinologist and geneticist, said: “We’re thrilled to work with amplifAI and their industry-leading technology. Cardiovascular aging and longevity share common pathophysiological mechanisms. Every 20 seconds, a limb is amputated globally. Delaying cardiovascular aging increases the likelihood of longevity, and tools like ampifAI’s AI-powered algorithms can help with early detection and surveillance”.

Also Read: MENADNA And Nebula Genomics Enter New Partnership

Dr. Meshari F. Alwashmi, CEO of amplifAI Health, added: “We’re tremendously excited to work with Healthspan, and our diverse team has what it takes to expand our sphere of knowledge regarding the application of thermography and AI on vascular aging. We hope to extend lifespan for the benefit of all humanity”.

amplifAI Health and Healthspan Digital’s integration of AI with thermal hyperspectral imaging offers an unprecedented opportunity for groundbreaking advancements in the field of medical diagnosis, enabling enhanced monitoring and evaluation of therapeutic interventions to fight vascular aging.